Navigation Links
MKM Partners Hires Biotechnology/Specialty Pharmaceuticals Analyst
Date:6/13/2011

STAMFORD, Conn., June 13, 2011 /PRNewswire/ -- MKM Partners today announced that Jon LeCroy, M.D., has joined as a Managing Director in its Equity Research department to cover biotechnology and specialty pharmaceuticals companies, inaugurating MKM's research expansion into the healthcare sector.

Dr. LeCroy covered the same sector at Hapoalim Securities USA most recently and at Natixis Bleichroeder and Goldman Sachs before that. He ranked #5 in this year's Wall Street Journal Best on the Street poll in Biotechnology. Dr. LeCroy holds an MBA from Boston University's Graduate School of Management, an M.D. from University of South Florida College of Medicine and a B.S. in biology from Wake Forest University. He will be based in MKM's Stamford headquarters.

"I am excited about the opportunity to join MKM Partners and plan to build on the firm's previous success by expanding research coverage into the healthcare industry," Jon remarked.

"Our move into the healthcare vertical expands MKM's research footprint," said MKM Partners CEO Richard R. Castellano. "Jon's in-depth and actionable research – and his stockpicking prowess – will make him a key resource for MKM's existing institutional equity client base and enable us to service new clients focused on investment opportunities in healthcare."

ABOUT MKM PARTNERS

MKM Partners is an institutional equity research, sales and trading firm. Headquartered in Stamford, Connecticut, with offices in New York City, Boston and across the U.S., MKM provides clients with actionable and unbiased economic, technical, derivatives, event-driven and fundamental research and has trade execution abilities in U.S. and foreign equity markets and in U.S. options markets. In addition to offering timely access to its traders and analysts, MKM focuses on delivering exceptional service to institutional clients across its trading and research platforms. More information about MKM Partners can be accessed at www.mkmpartners.com.

For more information, contact:

Richard R. Castellano, CEO

(203) 861-9060


'/>"/>
SOURCE MKM Partners
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. The Pittsburgh Life Sciences Greenhouse Announces Innovative Partnership With University of Pittsburgh Biomedical Engineering Society
2. Pfizer Inc. and PAREXEL International Corp. Sign Strategic Partnership Agreement to Advance Clinical Development
3. Local Partnership Addresses Lagging Scores and Interest in Science and Math Among Students
4. Jennerex and Partners Present Positive JX-594 Randomized Phase 2 Clinical Data Showing Promising Survival Benefit in Patients with Advanced Liver Cancer
5. Rules-Based Medicine, Inc. (RBM) Partners with Institut Pasteur to Boost Innovation in Translational Research
6. Aperio Partners with Definiens to Market Definiens Tissue Studio for Advanced Image Analysis
7. John McKearn, Ph.D., Promoted to Managing Director of RiverVest Venture Partners
8. Mitsubishi Chemical Corporation Signs Memorandum of Understanding for Strategic Partnership With Genomatica for Sustainable Chemicals in Asia
9. Omnicare Clinical Research Acquired by Nautic Partners, LLC
10. CBI Announces Partnership With Childrens Rare Disease Network and The Global Genes Project
11. Lifeline Skin Care™ Selects Click Here, Inc., Richards Partners
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... ... 23, 2016 , ... STACS DNA Inc., the sample tracking software company, today ... Laboratory, has joined STACS DNA as a Field Application Specialist. , “I am ... and COO of STACS DNA. “In further expanding our capacity as a scientific integrator, ...
(Date:6/23/2016)... Apellis Pharmaceuticals, Inc. today announced positive ... its complement C3 inhibitor, APL-2. The trials were ... studies designed to assess the safety, tolerability, pharmacokinetics ... healthy adult volunteers. Forty subjects were ... dose (ranging from 45 to 1,440mg) or repeated ...
(Date:6/23/2016)... 2016 Andrew D ... http://doi.org/10.17925/OHR.2016.12.01.22 Published recently in ... from touchONCOLOGY, Andrew D Zelenetz , discusses ... care is placing an increasing burden on healthcare ... therapies. With the patents on many biologics expiring, ...
(Date:6/23/2016)... ... June 23, 2016 , ... ClinCapture, ... Pennsylvania Convention Center and will showcase its product’s latest features from June 26 ... presenting a scientific poster on Disrupting Clinical Trials in The Cloud during the ...
Breaking Biology Technology:
(Date:5/24/2016)... superior patient care by providing unparalleled technology to leaders of the medical imaging industry. ... recently added to the range of products distributed by Ampronix. Photo - ... ... ... ...
(Date:5/12/2016)... WearablesResearch.com , a brand of Troubadour ... from the Q1 wave of its quarterly wearables survey. ... receptivity to a program where they would receive discounts ... company. "We were surprised to see that ... LaColla , CEO of Troubadour Research, "primarily because there ...
(Date:4/28/2016)... BANGALORE, India , April 28, 2016 ... of Infosys (NYSE: INFY ), and Samsung SDS, ... partnership that will provide end customers with a more ... payment services.      (Logo: http://photos.prnewswire.com/prnh/20130122/589162 ) ... financial services, but it also plays a fundamental part in ...
Breaking Biology News(10 mins):